Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지

Functional Modification of a Specific RNA with Targeted Trans-Splicing

  • Park, Young-Hee (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University) ;
  • Kim, Sung-Chun (Genoprot Inc.) ;
  • Kwon, Byung-Su (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University) ;
  • Jung, Heung-Su (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University) ;
  • Kim, Kuchan (National Institute of Health) ;
  • Lee, Seong-Wook (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
  • Published : 2004.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The self-splicing group I intron from Tetrahymena thermophila has been demonstrated to perform splicing reaction with its substrate RNA in the trans configuration. In this study, we explored the potential use of the trans-splicing group I ribozymes to replace a specific RNA with a new RNA that exerts any new function we want to introduce. We have chosen thymidine phosphorylase (TP) RNA as a target RNA that is known as a valid cancer prognostic factor. Cancer-specific expression of TP RNA was first evaluated with RT-PCR analysis of RNA from patients with gastric cancer. We determined next which regions of the TP RNA are accessible to ribozymes by employing an RNA mapping strategy, and found that the leader sequences upstream of the AUG start codon appeared to be particularly accessible. A specific ribozyme recognizing the most accessible sequence in the TP RNA with firefly luciferase transcript as a 3' exon was then developed. The specific trans-splicing ribozyme transferred an intended 3' exon tag sequence onto the targeted TP transcripts, resulting in a more than two fold induction of the reporter activity in the presence of TP RNA in mammalian cells, compared to the absence of the target RNA. These results suggest that the Tetrahymena ribozyme can be a potent anti-cancer agent to modify TP RNAs in tumors with a new RNA harboring anti-cancer activity.

Keywords

References

  1. Been, M. and Cech, T. (1986). One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity, Cell 47, 207-216 https://doi.org/10.1016/0092-8674(86)90443-5
  2. Brown, N. S., Jones, A, Rujiyama, C., Harris, A. L., and Bicknell, R. (2000). Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 60, 6298-6302
  3. Byun, J., Lan, N., Long, M., and Sullenger, B. A. (2003). Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. RNA 9, 1254-1263 https://doi.org/10.1261/rna.5450203
  4. Feramisco, J. R., Smart, J. E., Burridge, K., Helfman, D. M., and Thomas, G. P. (1982). Co-xistence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle. J BioI. Chem. 257, 11024-11031
  5. Fox, S. B., Moghaddam, A, and Westwood, M. (1995). Plateletderived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol. 176, 183-190 https://doi.org/10.1002/path.1711760212
  6. Furukawa, T., Yoshimura, A, and Yamada, Y. (1992). Angiogenic factor. Nature 356, 668
  7. Ikeda, R., Furukawa, T., Yamada, K., and Akiyama, S. (2002). Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-Deoxy-D-ribose. Biochem. Biophys. Res. Commun. 291, 806-812 https://doi.org/10.1006/bbrc.2002.6432
  8. Ikeda, R., Furukawa, T., Yamada, K., and Akiyama, S. (2003). Thymidine phosphorylase inhibits apoptosis induced by cisplatin. Biochem. Biophys. Res. Commun. 301, 358-363 https://doi.org/10.1016/S0006-291X(02)03034-6
  9. IItzsch, M. H., Kouni, M. H., and Cha, S. (1985). Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24, 6799-6807 https://doi.org/10.1021/bi00345a011
  10. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C.-H. (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338, 557-562 https://doi.org/10.1038/338557a0
  11. Jones, J. T., Lee, S.-W., and Sullenger, B. A. (1996). Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2, 643-648 https://doi.org/10.1038/nm0696-643
  12. Kohler, U., Ayre, B. G., Goodman, H. M., and Haseloff, J. (1999). Trans-splicing ribozymes for targeted gene delivery, J Mol. Biol. 185, 1935-1950
  13. Lan, N., Howrey, R. P., Lee, S.-W., Smith, C. A, and Sullenger, B. A (1998). Ribozyme-mediated repair of sickle $\beta$ -globin mRNAs in erythrocyte precursors. Science 280, 1593-1596 https://doi.org/10.1126/science.280.5369.1593
  14. Lan, N., Rooney, B. L., Lee, S.-W., Howrey, R. P., Smith, C. A., and Sullenger, B. A. (2000). Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2, 245-255 https://doi.org/10.1006/mthe.2000.0125
  15. Luccioni, C., Beaumatin, J., Bardot, V., and Lefrancois, D. (1994). Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int. J. Cancer 58, 517-522 https://doi.org/10.1002/ijc.2910580411
  16. Mari, S., Takao, S., Nama, H., and Aikou, T. (2002). Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity. Biochem. Biophys. Res. Commun. 295, 300-305 https://doi.org/10.1016/S0006-291X(02)00662-9
  17. Phylactou, L. A., Darrah, C., and Wood, M., A., J. (1998). Ribozymemediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18, 378-381 https://doi.org/10.1038/ng0498-378
  18. Rogers, C. S., Vanoye, C. G., Sullenger, B. A., and George, Jr. A. L. (2002). Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J. Clin. Invest. 110, 1783-1798
  19. Ryu, K.-J., Kim, J.-H., and Lee, S.-W. (2003). Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395 https://doi.org/10.1016/S1525-0016(02)00063-1
  20. Shin, K.-S., Bae, S.-J., Hwang, E.-S., Jeong, S., and Lee, S.-W. (2002). Ribozyme-mediated replacement of p53 RNA by targeted trans-splicing. J. Microbiol. Biotechnol. 12, 844-848
  21. Sullenger, B. A. and Cech, T. R. (1994). Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317, 619-622
  22. Sullenger, B. A. and Cech, T. R. (1995). RNA repair: a new possibility for gene therapy. J. NIH Res. 7, 46-47
  23. Takebayashi, Y., Yamada, K., and Miyadera, K. (1996). The activity and expression of thymidine phosphorylase in human solid tumors. Eur. J. Cancer 32A, 1227-1232
  24. Watanabe, T. and Sullenger, B. A. (2000). Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. US4 97, 8490-8494 https://doi.org/10.1073/pnas.150104097